Zobrazeno 1 - 10
of 89
pro vyhledávání: '"Wilmosh, Mermershtain"'
Autor:
Keren Rouvinov, Eran Levanon, Avivit Peer, Michal Sarfaty, David Sarid, Victoria Neiman, Eduard Grikshtas, Eli Rosenbaum, Igal Kushnir, Barak Talmor, Michael Friger, Yonaton Zarbiv, Eli Gez, Hadas Dresler, Walid Shalata, Amichay Meirovitz, Noa Shani Shrem, Alexander Yakobson, Wilmosh Mermershtain, Daniel Keizman
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundErdafitinib, a fibroblast growth factor receptor (FGFR) inhibitor is a standard post chemotherapy advanced treatment line for metastatic urothelial carcinoma harboring FGFR2/3 genomic alterations. It was approved based on a phase 2 clinical
Externí odkaz:
https://doaj.org/article/5d97724776e04b738ec6fc3ae439db56
Autor:
Keren Rouvinov, Endre Z. Neulander, Elena Kan, Murad Asali, Samuel Ariad, Wilmosh Mermershtain
Publikováno v:
Case Reports in Oncology, Vol 10, Iss 1, Pp 388-391 (2017)
Testicular metastases from renal cell carcinoma (RCC) are extremely rare. To the best of our knowledge, only 33 cases have been described in the literature. Most of the reported cases are of unilateral testicular metastasis from RCC. We report a case
Externí odkaz:
https://doaj.org/article/19e4497b504345ffa440dde95a5e67ea
Autor:
Lidia Osyntsov, Keren Rouvinov, Wilmosh Mermershtain, Samuel Ariad, Nina Bar-Am, Ruthy Shaco-Levy
Publikováno v:
Clinical Genitourinary Cancer. 15:e1127-e1130
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8656f50ced6dbcd59b200f9338c793e
https://doi.org/10.1016/j.clgc.2017.05.028
https://doi.org/10.1016/j.clgc.2017.05.028
Autor:
Elena Kan, Endre Z. Neulander, Samuel Ariad, Wilmosh Mermershtain, Murad Asali, Keren Rouvinov
Publikováno v:
Case Reports in Oncology, Vol 10, Iss 1, Pp 388-391 (2017)
Case Reports in Oncology
Case Reports in Oncology
Testicular metastases from renal cell carcinoma (RCC) are extremely rare. To the best of our knowledge, only 33 cases have been described in the literature. Most of the reported cases are of unilateral testicular metastasis from RCC. We report a case
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38929994cbe77c8d2fac42bacea6a8b6
http://www.karger.com/Article/FullText/473698
http://www.karger.com/Article/FullText/473698
Autor:
Maya Gottfried, Gedske Daugaard, M-C Desax, Keren Rouvinov, J Mueller, M O Fosboel, Avivit Peer, David Sarid, Peter Meidahl Petersen, Aurelius Omlin, Hadas Dresler, Victoria Neiman, Daniel Keizman, Richard Cathomas, Silke Gillessen, Eli Rosenbaum, Hermann Reichegger, Jann Mortensen, Wilmosh Mermershtain
Publikováno v:
Prostate Cancer and Prostatic Diseases. 20:289-293
The imaging response to radium-223 therapy is at present poorly described. We aimed to describe the imaging response to radium-223 treatment. We retrospectively evaluated the computed tomography (CT) and bone scintigraphy response of metastatic castr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd9f204af927b2e2429796dbe5c5af66
https://doi.org/10.1038/pcan.2017.6
https://doi.org/10.1038/pcan.2017.6
Autor:
Endre Z. Neulander, Samuel Ariad, Hadas Dresler, Daniel Keizman, Amos Douvdevani, Wilmosh Mermershtain, Keren Rouvinov, Reut Riff, Noa Shani-Shrem
Publikováno v:
Oncology Research and Treatment. 40:707-710
Background: Limited data about biomarkers are available to predict the outcomes of targeted therapy in metastatic renal cell carcinoma (mRCC). Circulating cell-free DNA (CFD) is elevated in various cancers. Patients and Methods: We performed a prospe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5609e56c10537c7662c6489c409afe8f
https://doi.org/10.1159/000479523
https://doi.org/10.1159/000479523
Autor:
David Sarid, Avivit Peer, Michael A. Carducci, Avishay Sella, Eli Rosenbaum, Raanan Berger, Daniel Keizman, Victoria J. Sinibaldi, Maya Ish-Shalom, Hans J. Hammers, Mario A. Eisenberger, Victoria Neiman, Keren Rouvinov, Wilmosh Mermershtain, Natalie Maimon, Maya Gottfried
Publikováno v:
Clinical Genitourinary Cancer. 14:420-425
Although studies in several cancer types suggest that metformin has antitumor activity, its effect on the outcome of targeted therapies in metastatic renal cell carcinoma (mRCC) is poorly defined. We aimed to analyze the effect of metformin use on th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05fdadd7e3d22c07a7700b2991f1bf03
https://doi.org/10.1016/j.clgc.2016.04.012
https://doi.org/10.1016/j.clgc.2016.04.012
Publikováno v:
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology
Objective: The aim was to investigate the value of postoperative brachytherapy for patients with Stage IB, Grade 2 endometrial carcinoma. Patients and Methods: Forty-six patients with Stage IB, Grade 2 endometrial carcinoma, were treated with simple
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77b601df114bb2d886bcb4c46c434dd5
http://europepmc.org/articles/PMC4854042
http://europepmc.org/articles/PMC4854042
Ipilimumab Treatment-Induced Distal Esophageal Dissection in a Patient with Advanced Prostate Cancer
Autor:
David, Yardeni, Ori, Galante, Lior, Fuchs, Daniela, Munteanu, Wilmosh, Mermershtain, Ruthy, Shaco-Levy, Yaniv, Almog
Publikováno v:
The Israel Medical Association journal : IMAJ. 18(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::190b83d468797c4c7e63a5af46e4d526
https://pubmed.ncbi.nlm.nih.gov/28471570
https://pubmed.ncbi.nlm.nih.gov/28471570
Autor:
Eli Rosenbaum, Ofer Purim, Avivit Peer, Moran Gadot, David Sarid, Noa Shani Shrem, Ialyzaveta Romanov, Keren Rouvinov, Gilad W. Vainer, Raanan Berger, Maya Collin, Hagai Ligumsky, Meital Levartovsky, Michal Sarfaty, Ruth Perets, Corinne Maurice-Dror, Victoria Neiman, Raya Leibowitz-Amit, Wilmosh Mermershtain
Publikováno v:
Journal of Clinical Oncology. 37:e16026-e16026
e16026 Background: The use of next generation sequencing (NGS) is in a constant rise, without clear evidence to its utility in guiding treatment choices in urologic malignancies. While platinum-based chemotherapy (chemo) is still the mainstay of trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32d51023e7632f2b2108a5a311d2677e
https://doi.org/10.1200/jco.2019.37.15_suppl.e16026
https://doi.org/10.1200/jco.2019.37.15_suppl.e16026